Artikel
Short-term changes of antihypertensive therapy according to the guidelines of the German Hypertension League
Kurzfristige Änderungen der antihypertensiven Therapie nach Leitlinienempfehlung der Deutschen Hochdruckliga
Suche in Medline nach
Autoren
Veröffentlicht: | 11. November 2004 |
---|
Gliederung
Text
Since November 2002, angiotensin-1 receptor antagonists (AT-1)are recommended as first-class drugs in antihypertensive therapy. We investigated the prescription behaviour of general practitioners during the first 6 months after the guidelines of the German Hypertension League have been changed.
Methods
255 hypertensive patients on drug therapy were prospectively investigated and compared to the data of a prospective study (n=100 hypertensive patients) performed between March and June 2002. Patients with blood pressure values < 140/90 mmHg were classified as adequately treated. All patients underwent cardiac catheterization. 48% of patients with coronary heart disease had interventional therapy. 62% of all patients received statin therapy. LDL cholesterol values were 116±36 U/l.
Results
In 2003, more hypertensive patients were treated with AT-1 and less with ACE inhibitors (ACE-I) and b-receptor blockers (b-B). There are no significant changes in diuretics (D) and calcium channel blockers (CCB) (Chi²-test).
Conclusions
In 2003, more hypertensive patients are treated with AT-1 receptor antagonists compared to 2002.